1.
Biotechniques
; 64(1): 9-10, 2018 01 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-29384071
RESUMEN
Newly engineered bacterial strains propel an immune-mediated cancer therapy toward clinical applications. Hannah Martin Lawrenz reports on the latest developments.